Abatacept biosimilar (Kashiv BioSciences)

阿巴西普生物类似药 (Kashiv BioSciences)

Report date: 2025/02/17 11:18:23

Base Information

Drug NameAbatacept biosimilar (Kashiv BioSciences)
Drug Alias NameKSHB-002KSHB002
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionCluster of differentiation 80 modulatorsCluster of differentiation 86 modulators
TargetsCluster of differentiation 80Cluster of differentiation 86
Therapy Area/IndicationsImmune System DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKashiv BioSciences LLC
China Registration ClassN/A

Develop Information

Active CompaniesKashiv BioSciences LLC
Inactive CompaniesN/A
Active IndicationsImmune System DiseasesArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A